Ignite Creation Date:
2024-05-06 @ 3:28 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04649021
Status:
COMPLETED
Last Update Posted:
2022-05-10
First Post:
2020-11-17
Brief Title:
Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine BNT162b2 in Chinese Healthy Population
Sponsor:
BioNTech SE
Organization:
BioNTech SE
Organization Data
Organization:
BioNTech SE
Class:
INDUSTRY
Study ID:
BNT162-06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BioNTech SE
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Shanghai Fosun Pharmaceutical Industrial Development Co Ltd | INDUSTRY |